The present invention PPAR- γ relates to a novel compound having activity and a medical, use thereof, in which the anti-inflammatory avian metabolites can be used in the present invention, as well as anti-inflammatory 15d-PGJ avian metabolites. 2 The (PPAR- γ main structural motifs of Ligolipogo) biLithospermene PPAR- γ is combined to synthesize an aromatic ring enone jasmonate derivative, which acts as a secondary active agent, and is used as, 15d-PGJ an active ingredient. 2 The exoskeleton enone moiety of PPAR- γ is essential for the covalent bond of the cysteine residues of the ligand (Cys285)-binding domain with the cysteine residue of the, ligand-binding domain, as described above. As a PPAR- γ result, it was confirmed that, the compound of the present invention can be useful in the development of a clinically applicable. secondary ligand as a diabetes and anti-inflammatory agent, PPAR- γ as shown in SEQ ID No.2.5.